Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. NX
NX logo

NX Should I Buy

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Should You Buy Quanex Building Products Corp (NX) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion
Hold
Latest Price
20.460
1 Day change
-2.43%
52 Week Range
22.980
Analysis Updated At
2026/04/17
Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.
Sign Up

Quanex Building Products Corp (NX) is not a strong buy for a beginner, long-term investor at this moment. While the technical indicators show some bullish signals, the company's financial performance is weak, with a significant drop in net income and EPS. Additionally, there are no strong positive catalysts or recent news to drive the stock higher. The options data also does not indicate strong bullish sentiment. For a beginner investor with a long-term focus, it would be prudent to wait for clearer signs of financial recovery or stronger market sentiment before investing.

Technical Analysis

The MACD is positive and contracting, indicating mild bullish momentum. The RSI is neutral at 50.766, and moving averages are bullish (SMA_5 > SMA_20 > SMA_200). Key support is at 17.618, and resistance is at 20.178. However, the stock shows only a 50% chance of a 7.07% increase over the next month, which is not a strong bullish signal.

Options Data

Bullish
Open Interest Put-Call Ratio
Bullish
Option Volume Put-Call Ratio

Technical Summary

StrongSellSellNeutralBuyStrongBuydotted line Image
Sell
4
Buy
9

Positive Catalysts

  • Bullish moving averages and slight revenue growth YoY (+2.26%).

Neutral/Negative Catalysts

  • Significant drop in net income (-72.65%) and EPS (-71.88%) YoY. No recent news or influential trading activity. Weak sentiment from hedge funds and insiders.

Financial Performance

In Q1 2026, revenue grew by 2.26% YoY to $409.09M, but net income dropped significantly by -72.65% YoY to -$4.07M. EPS also declined by -71.88% YoY to -$0.09. Gross margin improved slightly by 7.52% YoY to 18.16%. Overall, financial performance is weak.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

No data on analyst ratings or price target changes.

Wall Street analysts forecast NX stock price to rise
1 Analyst Rating
Wall Street analysts forecast NX stock price to rise
1 Buy
0 Hold
0 Sell
Moderate Buy
Current: 20.970
sliders
Low
28
Averages
28
High
28
Current: 20.970
sliders
Low
28
Averages
28
High
28
Benchmark
analyst
Buy
maintain
$30 -> $28
AI Analysis
2025-12-15
Reason
Benchmark
analyst
Price Target
$30 -> $28
AI Analysis
2025-12-15
maintain
Buy
Reason
Benchmark lowered the firm's price target on Quanex to $28 from $30 and keeps a Buy rating on the shares. While FY26 guidance has been pushed to the company's Q1 results release, management's current view is for a flattish year-over-year comparison with the first half likely more challenged than the back half, notes the analyst, who is moving the firm's FY26 and FY27 EPS estimates lower given the uncertain outlook.

People Also Watch